Pharmaceutical Manufacturing of Haloperidol Tablets

The contract involves the manufacture of 5mg Haloperidol tablets adhering to USP standards, with packaging in bottles containing 100 tablets each. All production must meet full regulatory compliance including requirements for shelf-life validation, accurate labeling, and strict adherence to DEA regulations due to the controlled substance status of Haloperidol. The work is being solicited as a subcontract under the Department of Defense’s Medical Supply Chain Pharma FSA, with performance located at FPO, zip code 96632. The solicitation was posted on July 15, 2026, and responses are due by July 21, 2026, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing. The contract is part of a broader defense medical supply chain initiative, ensuring secure, compliant, and reliable access to this essential medication for military and Veteran healthcare systems.